Lumira Ventures, previously known as Lumira Capital, is a Canadian venture capital firm based in Toronto, Ontario, with offices in Vancouver, Montreal and Boston.
Organization
The Business Development Bank of Canada (BDC) is an investor in Lumira.[1]
Portfolio
In 2001, Lumira made a $14.5 million investment in Protiva Biotherapeutics.[2]
Other current and former portfolio companies include:[3]
- Alveolus
- AmacaThera
- Antios Therapeutics
- Antiva Biosciences
- Aurinia Pharmaceuticals
- Bardy Diagnostics
- BioTheryX
- Bright Angel Therapeutics
- Cardiac Dimensions
- Ception Therapeutics
- Congruence Therapeutics
- Corus Pharmaceuticals
- Corvia Medical
- Cyrano Therapeutics
- DAMONA Pharmaceuticals
- Deka BioSciences
- Depomed
- Edesa Biotech
- Endotronix
- Engage Therapeutics
- enGene
- ESSA Pharma
- Exact Imaging
- Forbius
- Fusion Pharmaceuticals
- G1 Therapeutics
- GenEp
- Guava Technologies
- HistoSonics
- IMV
- ISTA Pharmaceuticals
- Iterion Therapeutics
- KAI Pharmaceuticals
- KalGene
- KisoJi Biotechology
- LAVA Medtech Acquisition Corp.
- MAKO Surgical
- Medexus Pharmaceuticals
- Morphotek
- Notch Therapeutics
- OncoMyx Therapeutics
- Opsens
- OsteoQC
- Pharmasset
- PIC Therapeutics
- Resonant Medical
- Satsuma Pharmaceuticals
- Specific Biologics
- Spinal Kinetics
- Swift Medical
- Think Research
- Thryv Therapeutics
- U-Systems
- XyloCor Therapeutics
- X4 Pharmaceuticals
- Zymeworks
External links
Lumira Capital. Business Development Bank of Canada. Retrieved April 27, 2022, from http://archive.today/2022.04.28-044715/https://www.bdc.ca/en/bdc-capital/venture-capital/portfolio/lumira-capital-ii ↩︎
FOI Request - HTH-2015-51828. (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf ↩︎
Portfolio. Lumira. Retrieved March 26, 2023, from https://web.archive.org/web/20230326213612/https://www.lumiraventures.com/portfolio-companies/ ↩︎
